Comparison of Drug-Eluting and Bare Metal Stents in Saphenous Vein Grafts. Immediate and Long-Term Results;Comparación de los stents liberadores de fármaco y los convencionales en puentes de safena. Resultados inmediatos y a largo plazo

Revista Espanola de Cardiologia

Volumn 62, Issue 1, 2009, Pages 39-47

  Lozano, Íñigo ^a   García Camarero, Tamara ^b   Carrillo, Pilar ^c   Baz, José A ^d   de la Torre, José M ^b   López Palop, Ramón ^c   Pinar, Eduardo ^e   Salvatella, Neus ^d   Avanzas, Pablo ^a   Valdés, Mariano ^e  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Servicio de Cardiologia Hospital Marques de Valdecilla Santander Cantabria Espana   (Spain)

^c Servicio de Cardiología Hospital San Juan   (Spain)

^d HOSPITAL DO MEIXOEIRO   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Coronary angioplasty; Coronary bypass grafting; Revascularization; Stent

Indexed keywords

ABCIXIMAB; HEPARIN;

ACUTE CORONARY SYNDROME; ARTICLE; BARE METAL STENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DISEASE SEVERITY; DRUG ELUTING STENT; HEART DEATH; HEART MUSCLE REVASCULARIZATION; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; SAPHENOUS VEIN GRAFT; STENT; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; VEIN GRAFT;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAUSE OF DEATH; COHORT STUDIES; CORONARY ARTERY BYPASS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; SAPHENOUS VEIN; STENTS; SURVIVAL; TREATMENT OUTCOME;

EID: 59749085264     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70019-3     Document Type: Article

References (27)

1. Salomon N.W., Page U.S., Bigelow J.C., Krause A.H., Okies J.E., and Metzdorff M.T. Reoperative coronary surgery. Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass. J Thorac Cardiovasc Surg 100 (1990) 250-259
2. Savage M.P., Douglas Jr. J.S., Fischman D.L., Pepine C.J., King III S.B., Werner J.A., et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med 337 (1997) 740-747
3. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban H.E., Perin M., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
4. Bansal D., Muppidi R., Singla S., Sukhija R., Zarich S., Mehta J.L., et al. Percutaneous intervention on the saphenous vein bypass grafts-Long-term outcomes. Catheter Cardiovasc Interven 71 (2008) 58-61
5. Chu W.W., Rha S.W., Kuchulakanti P.K., Cheneau E., Torguson R., Pinnow E., et al. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 97 (2006) 34-37
6. Ellis S.G., Kandzari D., Kereiakes D.J., Pichard A., Huber K., Resnic F., et al. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient casecontrol study. J Invasive Cardiol 19 (2007) 404-409
7. Ge L., Iakovou I., Sangiorgi G.M., Chieffo A., Melzi G., Cosgrave J., et al. Treatment of saphenous vein graft lesions with drugeluting stents: immediate and midterm outcome. J Am Coll Cardiol 45 (2005) 989-994
8. Hoffmann R., Pohl T., Koster R., Blindt R., Boeckstegers P., and Heitzer T. Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study. Heart 93 (2007) 331-334
9. Hoye A., Lemos P.A., Arampatzis C.A., Saia F., Tanabe K., Degertekin M., et al. Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease. J Invasive Cardiol 16 (2004) 230-233
10. Lee M.S., Shah A.P., Aragon J., Jamali A., Dohad S., Kar S., et al. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv 66 (2005) 507-511
11. Price M.J., Sawhney N., Kao J.A., Madrid A., Schatz R.A., and Teirstein P.S. Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions. Catheter Cardiovasc Interv 65 (2005) 208-211
12. Pucelikova T., Mehran R., Kirtane A.J., Kim Y.H., Fahy M., Weisz G., et al. Short- and long-term outcomes after stentassisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. Am J Cardiol 101 (2008) 63-68
13. Tsuchida K., Ong A.T., Aoki J., Van Mieghem C.A., Rodriguez- Granillo G.A., Valgimigli M., et al. Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents. Am J Cardiol 96 (2005) 395-398
14. Vermeersch P., Agostoni P., Verheye S., Van Den H.P., Convens C., Van Den B.F., et al. Increased late mortality after sirolimuseluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol 50 (2007) 261-267
15. Baz J., Mauri J., Pinar E., and Albarrán A. Registro Español de Hemodinámica y Cardiología Intervencionista. XVI Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2006). Rev Esp Cardiol 60 (2007) 1273-1289
16. Baim D.S. Percutaneous treatment of saphenous vein graft disease: the ongoing challenge. J Am Coll Cardiol 42 (2003) 1370-1372
17. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (2006) e166-e286
18. Lozano I., López-Palop R., Pinar E., Saura D., Fuertes J., Rondán J., et al. Implante de stent directo en puentes de safena. Resultados inmediatos y a largo plazo. Rev Esp Cardiol 58 (2005) 270-277
19. Vermeersch P., Agostoni P., Verheye S., Van Den H.P., Convens C., Bruining N., et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol 48 (2006) 2423-2431
20. Roffi M., Mukherjee D., Chew D.P., Bhatt D.L., Cho L., Robbins M.A., et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation 106 (2002) 3063-3067
21. Silber S., Albertsson P., Aviles F.F., Camici P.G., Colombo A., Hamm C., et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26 (2005) 804-847
22. Ellis S.G. "Crying fire in a theater" or a "confirmatory sighting"?. J Am Coll Cardiol 50 (2007) 268-269
23. Hong M.K., Mehran R., Dangas G., Mintz G.S., Lansky A., Kent K.M., et al. Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplasty. Am J Cardiol 85 (2000) 256-258
24. Ruygrok P.N., Webster M.W., Ardill J.J., Chan C.C., Mak K.H., Meredith I.T., et al. Vessel caliber and restenosis: a prospective clinical and angiographic study of NIR stent deployment in small and large coronary arteries in the same patient. Catheter Cardiovasc Interv 59 (2003) 165-171
25. Maiello L., Colombo A., Gianrossi R., Goldenberg S., Martini G., and Finci L. Favourable results of treatment of narrowed saphenous vein grafts with Palmaz-Schatz stent implantation. Eur Heart J 15 (1994) 1212-1216
26. Tan K.H., Henderson R.A., Sulke N., Cooke R.A., Karani S., and Sowton E. Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting: ten years' experience. Cathet Cardiovasc Diagn 32 (1994) 11-17
27. Waksman R., Weintraub W.S., Ghazzal Z., Scott N.A., Shen Y., King S.B., et al. Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty. Am Heart J 134 (1997) 274-281